The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Activity-dependent protein synthesis is crucial for synaptic function and dendritic spine morphology.
• Dysregulation of this process is a hallmark of Fragile X syndrome (FXS).
• Matrix Metalloproteinase 9 (MMP-9) influences dendritic spine architecture and is implicated in FXS mouse models.

Purpose of the Study:

• To investigate the role of MMP-9 mRNA regulation in synaptic dysfunction in Fragile X syndrome.
• To determine if MMP-9 mRNA is associated with the Fragile X mental retardation protein (FMRP) complex.
• To elucidate the mechanism linking FMRP absence to altered MMP-9 levels at synapses.

Main Methods:

• Immunoprecipitation of FMRP complex to isolate associated mRNAs.
• In situ hybridization and immunofluorescence to detect MMP-9 mRNA and FMRP colocalization in dendrites.
• Analysis of MMP-9 mRNA translation in synaptoneurosomes from wild-type and Fmr1 knock-out mice.

Main Results:

• MMP-9 mRNA was found to be a component of the FMRP complex.
• MMP-9 mRNA colocalizes with FMRP in neuronal dendrites.
• Translation of MMP-9 mRNA is significantly increased at synapses in the absence of FMRP (Fmr1 knock-out mice).

Conclusions:

• The FMRP complex normally regulates MMP-9 mRNA translation at synapses.
• Loss of FMRP leads to elevated MMP-9 translation, contributing to synaptic abnormalities in FXS.
• Targeting MMP-9 activity may offer a therapeutic strategy for FXS-related synaptic dysfunction.